Literature DB >> 11218705

[A novel adult case of acute necrotizing encephalopathy of childhood with bilateral symmetric thalamic lesions].

Y Nakamura1, K Miura, I Yamada, H Ino, T Mizobata.   

Abstract

This report describes a 46-year-old Japanese woman with bilateral symmetric thalamic necrosis. The unusual radiologic findings are discussed in relation with acute necrotizing encephalopathy (ANE) of childhood, a rare disease proposed by Mizuguchi et al. ANE affects young children and the incidence is highest between 6 and 18 months of ages. There is only one report of an adult case. The acute stage pathology in ANE can be summarized as acute edema and necrosis involving both gray and white matter by local breakdown of the blood-brain barrier. The radiologic findings in our case were similar to those in ANE of childhood. Though the pathogenesis between our adult case and ANE of childhood might be different, severe hypoalbuminea in our case could cause the alteration of permeability of the thalamic vessels, which might accelerate breakdown of the blood-brain barrier in the thalamus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11218705

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  3 in total

1.  Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.

Authors:  Katharina Wolf; Thomas Schmitt-Mechelke; Spyridon Kollias; Armin Curt
Journal:  J Neurol       Date:  2013-01-18       Impact factor: 4.849

2.  Elderly-onset acute necrotizing encephalopathy mimicking severe heat stroke: a case report and review of the literature.

Authors:  Arisa Odagiri; Ayumu Yamaoka; Kei Miyata; Naofumi Bunya; Takehiko Kasai; Yoshihiro Takeyama; Shuji Uemura; Takeshi Mikami; Eichi Narimatsu
Journal:  Acute Med Surg       Date:  2019-04-11

Review 3.  Roles of Nucleoporin RanBP2/Nup358 in Acute Necrotizing Encephalopathy Type 1 (ANE1) and Viral Infection.

Authors:  Jing Jiang; Yifan E Wang; Alexander F Palazzo; Qingtang Shen
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.